Ticker · CUSIP 28658R106

CLYM

ELIEM THERAPEUTICS INC
···Share
Holders (tracked)
6
Combined shares
4,062,988
Combined value
$8.57M
Last close
Quarter
2025Q4
Tracked holders · last 8 quarters
+2 vs previous quarter over the last 8.
642024Q12025Q4

SEC event timeline

11 events
  1. +1,396,722 shares · 2025Q4
    Position
  2. +454,031 shares · 2025Q4
    Position
  3. +239,043 shares · 2025Q4
    Position
  4. −175,390 shares · 2025Q4
    Position
  5. +716,680 shares · 2025Q4
    Position
  6. −216,500 shares · 2025Q4
    Position
  7. −28,890 shares · 2025Q3
    Position
  8. −8,374 shares · 2025Q3
    Position
  9. −66,910 shares · 2025Q3
    Position
  10. −21,048 shares · 2025Q3
    Position
  11. +41,600 shares · 2025Q3
    Position

Insider activity

No insider transactions in the last 30 days.

Who moved on this name in 2025Q4

Position changes reported for the latest quarter, grouped by direction.
New positions2
Added to2
Trimmed2
Exited0

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
3
$4.4M
2022Q2
4
$507K
2022Q3
4
$471
2022Q4
3
$119K
2023Q1
3
$95K
2023Q2
3
$354K
2023Q3
3
$314K
2023Q4
4
$213K
2024Q1
4
$219K
2024Q2
3
$3.1M
2024Q3
6
$4.1M
2024Q4
5
$1.3M
2025Q1
6
$1.1M
2025Q2
6
$1.6M
2025Q3
4
$2.3M
2025Q4
6
$8.6M

Who owns CLYM

6 super-investors · 2025Q4
Tracked stake
4.06M
shares
Combined value
$9M
% of shares outstanding
shares-out unknown
Quarter action mix
New2Added2Trim2
#ManagerSharesValue
1Steve Cohen
Point72
716.7K$3M
2Two Sigma Investments566.7K$2M
3Renaissance Technologies320.6K$1M
4Izzy Englander
Millennium Mgmt
296.3K$1M
5Ken Griffin
Citadel Advisors
239.0K$956K
6T. Rowe Price1.92M$8K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live CLYM chart.
<iframe src="https://openstocks.me/embed/stock/CLYM" width="100%" height="480" frameborder="0" loading="lazy" title="CLYM chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>